| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |